Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
174,802
Total Claims
$43.0M
Drug Cost
124,718
Beneficiaries
$345
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-99%
Opioid rate vs peers
0.0% vs 2.2% avg
-76%
Cost per patient vs peers
$345 vs $1,411 avg
+835%
Brand preference vs peers
99.4% vs 10.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
Brand vs Generic
Brand: 173,654 claims · $42.9M
Generic: 1,106 claims · $77K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rsvpref3 Antigen/As01e/Pf | 54,169 | $17.3M |
| Varicella-Zoster Ge/As01b/Pf | 79,194 | $17.1M |
| Rsv Vacc, Pref A And Pref B/Pf | 21,245 | $7.0M |
| Diphth,pertuss(Acell),tet Vac | 13,415 | $880K |
| Hepatitis A And B Vaccine/Pf | 2,868 | $424K |
| Diph,pertuss(Acell),tet Vac/Pf | 1,688 | $114K |
| Naloxone Hcl | 875 | $94K |
| Hepatitis A Virus Vaccine/Pf | 256 | $26K |
| Hpv Vaccine 9-Valent/Pf | 66 | $21K |
| Typhoid Vi Polysacch Vaccine | 113 | $16K |
| Apixaban | 31 | $10K |
| Mening Vac A,c,y,w135,c-Tet/Pf | 47 | $8,817 |
| Hepatitis A Virus Vaccine/Pf | 84 | $8,314 |
| Measles,mumps,rubella Vacc/Pf | 64 | $7,328 |
| Tetanus-Diphtheria Toxoids/Pf | 51 | $3,070 |
Prescribing Profile
Patient Profile
73
Avg Age
58%
Female
1.07
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data